CAPITAL MEDICAL CENTER
1. Target Overview & Investment Thesis
CAPITAL MEDICAL CENTER is a 107-bed under-performing / distressed in THURSTON, WA with $123.5M in net patient revenue and a -22.2% operating margin. The hospital serves a payer mix of 36.6% Medicare, 1.7% Medicaid, and 61.7% commercial.
Thesis: Undervalued. Our ML models identify $9.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -22.2% to -14.8% (+736bps).
| Net Revenue HCRIS | $123.5M |
| Current EBITDA COMPUTED | $-27.4M |
| Operating Margin COMPUTED | -22.2% |
| Occupancy HCRIS | 41.5% |
| Revenue / Bed COMPUTED | $1.2M |
| Net-to-Gross HCRIS | 16.8% |
| Distress Probability ML | 48.5% |
2. Market Context & Competitive Position
WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -22.2% places it below the state median. Among 30 size-comparable peers (54-214 beds), the median margin is -9.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (54-214), prioritizing same-state peers. 30 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CAPITAL MEDICAL CENTER (Target) | WA | 107 | $123.5M | -22.2% |
| ST. JOSEPH MEDICAL CENTER | WA | 208 | $750.0M | 1.9% |
| CENTRAL WASHINGTON HOSPITAL | WA | 176 | $550.9M | -2.0% |
| YAKIMA VALLEY MEMORIAL HOSPITA | WA | 208 | $522.3M | -10.4% |
| LEGACY SALMON CREEK HOSPITAL | WA | 178 | $479.7M | -5.2% |
| SWEDISH MEDICAL CENTER CHERRY | WA | 181 | $463.4M | -15.0% |
| PHD#1 DBA SKAGIT VALLEY HOSPI | WA | 137 | $414.3M | -17.9% |
| ST. JOHN MEDICAL CENTER | WA | 122 | $335.0M | -4.4% |
| SWEDISH ISSAQUAH | WA | 157 | $282.7M | -6.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $79K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-27.4M |
| + RCM Uplift | +$9.1M |
| Pro Forma EBITDA | $-18.3M |
| Current Margin | -22.2% |
| Pro Forma Margin | -14.8% |
| WC Released (1x) | $4.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-42.1M | $-89.6M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-42.1M | $-112.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-37.9M | $-95.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-37.9M | $-115.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-46.3M | $-121.3M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-46.3M | $-148.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 30 hospitals with 54-214 beds
- Same-state prioritization (n=31)
- Comp margins: P25=-17.2% / P50=-9.7% / P75=-2.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.